Showing results (51-60 of 190) with videos related to

Sort By:
Pageof 19
Pharmacotherapy|January 1, 1987
Spiramycin in the treatment of cryptosporidiosisA M Pilla, M J Rybak, P H Chandrasekar
Antimicrobial Agents and Chemotherapy|November 26, 1997
Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection modelH H Houlihan, R C Mercier, M J Rybak
Antimicrobial Agents and Chemotherapy|November 26, 1997
In vitro activities of an investigational quinolone, glycylcycline, glycopeptide, streptogramin, and oxazolidinone tested alone and in combinations against vancomycin-resistant Enterococcus faeciumR C Mercier, S R Penzak, M J Rybak
The Annals of Pharmacotherapy|March 13, 1998
Trimethoprim/sulfamethoxazole-induced tremor in a patient with AIDSR S Slavik, M J Rybak, S A Lerner
The Journal of Antimicrobial Chemotherapy|October 8, 1999
The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection modelJ R Aeschlimann, G W Kaatz, M J Rybak
Antimicrobial Agents and Chemotherapy|October 3, 1998
Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetationsJ R Aeschlimann, M J Zervos, M J Rybak
Annual Review of Medicine|January 1, 1981
Cardiac transplantationS A Hunt, E B Stinson
Cardiology in Review|February 15, 2001
Neoplasia after heart transplantationB W Kwok, S A Hunt
Antimicrobial Agents and Chemotherapy|March 18, 2000
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strainsM J Rybak, E Hershberger, T Moldovan, et al.
Antimicrobial Agents and Chemotherapy|February 27, 1999
Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methodsE Hershberger, J R Aeschlimann, T Moldovan, et al.
Pageof 19